Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-12-12

FDA Approved: NAPROXEN SODIUM — Supplemental Application (Bionpharma Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Naproxen Sodium from Bionpharma Inc., resulting in changes to the product labeling. This action confirms regulat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naproxen sodium (naproxen sodium)

Snippet

SUPPL AP for NAPROXEN SODIUM (NAPROXEN SODIUM)